His primary areas of investigation include Immunology, Acquired immunodeficiency syndrome, Virology, Virus and Internal medicine. He is involved in the study of Immunology that focuses on Immune system in particular. Robert T. Schooley has researched Acquired immunodeficiency syndrome in several fields, including Clinical research, MEDLINE, Viral disease, Intensive care medicine and Pharmacotherapy.
His Virology study integrates concerns from other disciplines, such as Cell culture, In vitro, Reverse transcriptase and Recombinant DNA. His biological study spans a wide range of topics, including Antibody, Menstrual cycle and Genitourinary system. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Surgery, AIDS-related complex and Zidovudine.
Robert T. Schooley spends much of his time researching Virology, Immunology, Virus, Acquired immunodeficiency syndrome and Internal medicine. His Virology research incorporates themes from Peripheral blood mononuclear cell, Antibody and Antigen. His Immunology study frequently links to adjacent areas such as Cytotoxic T cell.
The study incorporates disciplines such as T lymphocyte and Lymphocyte in addition to Virus. In his study, MEDLINE is strongly linked to Intensive care medicine, which falls under the umbrella field of Acquired immunodeficiency syndrome. His research investigates the connection with Internal medicine and areas like Gastroenterology which intersect with concerns in Zidovudine.
Robert T. Schooley mainly focuses on Virology, Antibiotics, Internal medicine, Microbiology and Phage therapy. His study in Virology is interdisciplinary in nature, drawing from both Antibody, Acquired immunodeficiency syndrome and Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019. His work on Nevirapine as part of general Acquired immunodeficiency syndrome research is frequently linked to In patient, bridging the gap between disciplines.
His research in Internal medicine intersects with topics in Raltegravir, Sarcoma and Metronidazole. Robert T. Schooley combines subjects such as Clinical trial, Intensive care medicine, Clinical microbiology, Antibiotic resistance and Bacteriophage Therapy with his study of Phage therapy. Recombinant soluble CD4 is a subfield of Immunology that Robert T. Schooley explores.
His primary areas of study are Internal medicine, Antibiotics, Microbiology, Adverse effect and 2019-20 coronavirus outbreak. His Internal medicine research includes elements of Raltegravir, Lamivudine and Etravirine. The various areas that Robert T. Schooley examines in his Microbiology study include Bilateral lung transplantation, Liver function and Lytic cycle.
His 2019-20 coronavirus outbreak research entails a greater understanding of Virology. His work carried out in the field of Virology brings together such families of science as Tumor necrosis factor alpha, Antibody and Immunity. His Bacteriophage study incorporates themes from Immunology, Bone Infection, Positive culture, Lung transplant recipient and Klebsiella pneumoniae.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework*
Arthur J. Atkinson;Wayne A. Colburn;Victor G. DeGruttola;David L. DeMets.
Clinical Pharmacology & Therapeutics (2001)
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo-controlled trial.
Margaret A Fischl;D. D. Richman;M. H. Grieco;M. S. Gottlieb.
The New England Journal of Medicine (1987)
Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
A. S. Fauci;J. G. Bartlett;E. P. Goosby;M. D. Smith.
Annals of Internal Medicine (1998)
Chronic Fatigue Syndrome: A Working Case Definition
Gary P. Holmes;Jonathan E. Kaplan;Nelson M. Gantz;Anthony L. Komaroff.
Annals of Internal Medicine (1988)
Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel
Charles C. J. Carpenter;David A. Cooper;Margaret A. Fischl;Jose M. Gatell.
Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency Syndrome
D D Ho;T R Rota;R T Schooley;J C Kaplan.
The New England Journal of Medicine (1985)
A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter
Scott M. Hammer;David A. Katzenstein;Michael D. Hughes;Holly Gundacker.
The New England Journal of Medicine (1996)
Treatment for adult HIV infection : 2006 recommendations of the international AIDS society-USA panel
Scott M. Hammer;Michael S. Saag;Mauro Schechter;Julio S. G. Montaner.
HIV-specific cytotoxic T lymphocytes in seropositive individuals.
Bruce D. Walker;Sekhar Chakrabarti;Bernard Moss;Timothy J. Paradis.
Vidarabine versus Acyclovir Therapy in Herpes Simplex Encephalitis
Richard J. Whitley;Charles A. Alford;Martin S. Hirsch;Robert T. Schooley.
The New England Journal of Medicine (1986)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: